Skip to main content
Market intelligence
RYTMHealthcare

Rhythm Pharmaceuticals Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 14, 2026David P MeekerPresident and CEOSale50,000$102.67$5,133,440
Aug 31, 2026Hunter C SmithChief Financial OfficerSale62,774$105.46$6,619,914
Aug 13, 2026Joseph ShulmanChief Technical OfficerSale5,079$119.75$608,210